Skip to Main Content

Paper Details

Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer.
Eur Urol Oncol
10
2022
BCR, Localized, Localized Prostate Cancer, Localized prostate tumors, PATIENT, genomic, multiple subclonal populations, patient, patients, prostate, prostate tumors, tumor
DNA, Genomics, Humans, Male, Neoplasm Recurrence, Local, Prognosis, Prostatic Neoplasms
Author NameAffiliation
Harry C BrastianosPrincess Margaret Cancer Center, University Health Network, Canada Ontario Institute for Cancer Research, Queen's University
Jure MurgicPrincess Margaret Cancer Center, University Health Network, University of Toronto
Adriana SalcedoOntario Institute for Cancer Research
Melvin L K ChuaPrincess Margaret Cancer Center, University Health Network, National Cancer Centre Singapore
Alice MengPrincess Margaret Cancer Center, University Health Network
Michael FraserPrincess Margaret Cancer Center, University Health Network, Canada Ontario Institute for Cancer Research
Michael BrundageQueen's University
Neil E FleshnerPrincess Margaret Cancer Centre, University Health Network
Theodorus H van der KwastUniversity Health Network
Robert G BristowPrincess Margaret Cancer Center, University Health Network, University of Toronto, Canada Manchester Cancer Research Center
Paul C BoutrosUniversity of Toronto, University of California, USA Broad Stem Cell Research Center, USA Institute for Precision Health, USA Jonsson Comprehensive Cancer Center los angeles
Alejandro BerlinPrincess Margaret Cancer Center, University Health Network, University of Toronto, Canada Techna Institute
  • 1 - 12

Datasets

Release 1.2